| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2174/157016110791112269 |
| P698 | PubMed publication ID | 19758115 |
| P50 | author | George D. Kitas | Q37831495 |
| Deborah P.M. Symmons | Q54100237 | ||
| Tracey E Toms | Q114716033 | ||
| P433 | issue | 3 | |
| P921 | main subject | dyslipidemia | Q66291209 |
| inflammation | Q101991 | ||
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 301-326 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Current Vascular Pharmacology | Q15751349 |
| P1476 | title | Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors | |
| P478 | volume | 8 |
| Q93083086 | A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis |
| Q36550836 | A novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis |
| Q43826908 | A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. |
| Q37728928 | A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis |
| Q34348277 | Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study. |
| Q36991049 | ApoE deficiency exacerbates the development and sustainment of a semi-chronic K/BxN serum transfer-induced arthritis model |
| Q36554649 | Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis |
| Q51673816 | Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? |
| Q36396428 | Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. |
| Q92462247 | Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis |
| Q35650155 | Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis |
| Q91778340 | Cardiovascular Comorbidities in Psoriatic Disease |
| Q54255528 | Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients. |
| Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
| Q36218375 | Cardiovascular disease and rheumatoid arthritis: an update |
| Q35929968 | Cardiovascular risk factors in women with primary Sjögren's syndrome: United Kingdom primary Sjögren's syndrome registry results |
| Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
| Q51211966 | Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients. |
| Q46796548 | Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors |
| Q35029916 | Dyslipidaemia in rheumatological autoimmune diseases |
| Q57751019 | Editorial: Do We Need a Disease-Specific Cardiovascular Risk Calculator for Patients With Rheumatoid Arthritis? |
| Q36013882 | Factors associated with parasympathetic activation following exercise in patients with rheumatoid arthritis: a cross-sectional study |
| Q53653844 | Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients. |
| Q33891946 | Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship? |
| Q50016514 | LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis |
| Q38554197 | Lipid and Metabolic Changes in Rheumatoid Arthritis. |
| Q38026796 | Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies |
| Q82470983 | Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy |
| Q47874353 | Physical Activity and Correlates of Physical Activity Participation Over Three Years in Adults With Rheumatoid Arthritis |
| Q38523001 | Platelet and red blood cell interactions and their role in rheumatoid arthritis. |
| Q44832625 | Predictors of endothelial dysfunction in patients with rheumatoid arthritis |
| Q36245670 | Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study |
| Q38149252 | Rheumatoid arthritis and cardiovascular disease |
| Q36812587 | Rheumatoid arthritis and cardiovascular disease: an update on treatment issues |
| Q50192090 | The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis |
| Q48075422 | The burden of disease in rheumatoid arthritis |
| Q37343272 | The impact of inflammation on metabolomic profiles in patients with arthritis |
| Q35069789 | Translating patient education theory into practice: developing material to address the cardiovascular education needs of people with rheumatoid arthritis. |
| Q50518814 | Tumor necrosis factor-α -308 polymorphism in North Indian rheumatoid arthritis patients and association with mRNA and serum TNF-α. |
Search more.